Category
Supplementary Resource
Organisation
Type
Standard
Version
2.3
Access
Open
Status
Active
Created
March 2021
Therapeutic Goods Order (TGO) 91 is the medicine labelling standard for prescription medicines and TGO 92 is the medicine labelling standard for non-prescription medicines. This document provides extensive guidance for sponsors and manufacturers on how to apply these standards.
The document provides detailed information about how information should be displayed on labels, including text size and colour contrast. It also includes specific guidance for different types of packaging, routes of administration and active ingredients. The label design best practice section covers topics including the use of capital letters, Braille and other languages; user-centred design; QR codes; the inclusion of additional information; and how to express the names and strength of active ingredients.
Main sections:
- Introduction
- Using the Orders
- Mandatory requirements - specific medicine types
- Recommendations and best practice
- Tabulated display of critical health information
The document provides detailed information about how information should be displayed on labels, including text size and colour contrast. It also includes specific guidance for different types of packaging, routes of administration and active ingredients. The label design best practice section covers topics including the use of capital letters, Braille and other languages; user-centred design; QR codes; the inclusion of additional information; and how to express the names and strength of active ingredients.
Main sections:
- Introduction
- Using the Orders
- Mandatory requirements - specific medicine types
- Recommendations and best practice
- Tabulated display of critical health information
Access Medicine labels: Guidance on TGO 91 and TGO 92 v2.3
By accessing this content, you are leaving this website. The Agency takes no responsibility for the accuracy of content on the destination page.